Status:

UNKNOWN

The Uninfected Ixodes Scapularis Human Tick Challenge Model

Lead Sponsor:

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborating Sponsors:

ZonMw: The Netherlands Organisation for Health Research and Development

Conditions:

Tick Bites

Tick Immunity

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

An innovative way to prevent multiple tick-borne diseases is an anti-tick vaccine, i.e. targeting the vector to prevent transmission of pathogens from the tick to the host. The rationale for an anti-t...

Detailed Description

This will be an, single centre, experimental study. The design of the study is similar to a human challenge trial, with the important exception that the subjects in this study are not experimentally i...

Eligibility Criteria

Inclusion

  • Age: 18 years and older;
  • Negative Borrelia VlsE1/pepC10 ELISA.

Exclusion

  • Known history of tick bites;
  • Positive Borrelia serology (VlsE1/PepC10 ELISA);
  • Known history or current suspicion on any tick-borne disease;
  • Chronic skin condition affecting the arm skin;
  • Inability to maintain the dressing for any reason;
  • Known immunodeficiency or autoimmune disease;
  • Use of systemic immunomodulating drugs or chemotherapy, current or in the past;
  • Chronic use of antibiotics;
  • Unable to give informed consent or do not have a thorough command of the Dutch language;
  • Refusal to participate in specimen collection and storage for future study related use;
  • Pregnant or breastfeeding women;
  • Not willing to use adequate contraception during the study period;
  • Red meat allergy (both medically confirmed and self-reported);
  • Use of investigational therapy and devices during the time of the study;
  • Any other condition that, in the opinion of the investigator, would make the patient unsuitable for enrolment or could interfere with the patient participating in and completing the study.

Key Trial Info

Start Date :

July 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2024

Estimated Enrollment :

7 Patients enrolled

Trial Details

Trial ID

NCT05965635

Start Date

July 1 2023

End Date

July 1 2024

Last Update

July 28 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

AUMC location AMC

Amsterdam-Zuidoost, North Holland, Netherlands, 1105 AZ